Search

everythinglearnresearchcommunity

for

Search:↓

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

The compound 4c showed strong potential as an anticancer agent.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

AMPK activation may reduce melanoma risk in red-haired individuals.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Quercitrin may help treat Alzheimer's by boosting brain cell signaling without causing tumors.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

New compounds show promise as nonsteroidal treatments for hair loss.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

MK-386 reduces sebum DHT levels.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.